BIOLIFE SOLUTIONS INC — Director's Dealing 2023

Jan 21, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOLIFE SOLUTIONS INC (BLFS)
CIK: 0000834365
Period of Report: 2023-01-18

Reporting Person: Schulz Marcus (Chief Revenue Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-01-18	Common Stock	S	3000	$25.04	Disposed	44975	Direct
2023-01-19	Common Stock	S	538	$22.93	Disposed	44437	Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2022.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.10, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F3: The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.